Frontlight ResearchEarly access
Trial site
The University of Kansas Cancer Center - North
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- Prostate cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 23 trials
- Phase 32 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Not yet recruiting1 trial
- Lead sponsor
- SWOG Cancer Research Network4 trials
- Dana-Farber Cancer Institute1 trial
- Jun Zhang, MD, PhD1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
- University of Kansas Medical Center1 trial
Running trials
Not yet recruiting
A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
Active, not recruiting
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
Active, not recruiting
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Completed
Completed
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026